Muñoz A - Search Results

1

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

Yamashita TE, Phair JP, Muñoz A, Margolick JB, Detels R, O'Brien SJ, Mellors JW, Wolinsky SM, Jacobson LP. Yamashita TE, et al. Among authors: munoz a. AIDS. 2001 Apr 13;15(6):735-46. doi: 10.1097/00002030-200104130-00009. AIDS. 2001. PMID: 11371688 Clinical Trial.

2

Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.

Tarwater PM, Gallant JE, Mellors JW, Gore ME, Phair JP, Detels R, Margolick JB, Muñoz A. Tarwater PM, et al. Among authors: munoz a. AIDS. 2004 Dec 3;18(18):2419-23. AIDS. 2004. PMID: 15622318

3

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.

Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP; Multicenter AIDS Cohort Study. Seaberg EC, et al. Among authors: munoz a. AIDS. 2005 Jun 10;19(9):953-60. doi: 10.1097/01.aids.0000171410.76607.f8. AIDS. 2005. PMID: 15905677

4

Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.

Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, Muñoz A. Schneider MF, et al. Among authors: munoz a. AIDS. 2005 Nov 18;19(17):2009-18. doi: 10.1097/01.aids.0000189864.90053.22. AIDS. 2005. PMID: 16260908

5

Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy.

Schneider MF, Margolick JB, Jacobson LP, Reddy S, Martinez-Maza O, Muñoz A. Schneider MF, et al. Among authors: munoz a. J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):389-92. doi: 10.1097/QAI.0b013e318246bfce. J Acquir Immune Defic Syndr. 2012. PMID: 22217679 Free PMC article.

6

Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.

Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Wada N, et al. Among authors: munoz a. AIDS. 2014 Jan 14;28(2):257-65. doi: 10.1097/QAD.0000000000000078. AIDS. 2014. PMID: 24105030 Free PMC article.

7

Virologic and immunologic values allowing safe deferral of antiretroviral therapy.

Phair JP, Mellors JW, Detels R, Margolick JB, Muñoz A. Phair JP, et al. Among authors: munoz a. AIDS. 2002 Dec 6;16(18):2455-9. doi: 10.1097/00002030-200212060-00011. AIDS. 2002. PMID: 12461420

8

Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy.

Yamashita TE, Modjarrad K, Muñoz A. Yamashita TE, et al. Among authors: munoz a. AIDS. 2003 May 23;17(8):1264-6. doi: 10.1097/00002030-200305230-00023. AIDS. 2003. PMID: 12819533 No abstract available.

9

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP. Detels R, et al. Among authors: munoz a. JAMA. 1998 Nov 4;280(17):1497-503. doi: 10.1001/jama.280.17.1497. JAMA. 1998. PMID: 9809730

10

Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.

Jacobson LP, Yamashita TE, Detels R, Margolick JB, Chmiel JS, Kingsley LA, Melnick S, Muñoz A. Jacobson LP, et al. Among authors: munoz a. J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S34-41. J Acquir Immune Defic Syndr. 1999. PMID: 10430217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,647 results

Search Page

Filters